Reports and Insights
Your centralized hub for AdvaMed’s annual and quarterly reports, offering insights into our progress, priorities, and impact across the medtech ecosystem.
Each report reflects how we advocate for innovation, strengthen patient access, and advance policies that support a dynamic and evolving industry.
Overview
Our reports tell the story of medtech in action. From policy wins and global advocacy to financial strength and industry leadership, these insights highlight howAdvaMed® continues to deliver value for our members and the patients they serve.
Explore annual and quarterly reports to track momentum, understand key developments, and see where the industry is headed next.
Q2 2026 Quarterly Report
The Q2 2026 Report highlights AdvaMed®’s progress in advancing policies that support innovation, strengthen regulatory certainty, and expand patient access to life-changing medical technologies.
From finalizing the MDUFA VI commitment letter to advancing Medicare coverage, AI, and digital health priorities, this report showcases the advocacy, member engagement, and strategic actions driving momentum for the medtech industry..
2025 Annual Report
The 2025 Annual Report highlights a milestone year forAdvaMed® as we build on five decades of leadership and advocacy.
This report captures major policy achievements, membership growth, financial performance, and the expanding role of medtech across health care settings worldwide.
Access prior Annual Reports to explore how AdvaMed’s work and impact have evolved year over year.
These reports provide historical context on policy priorities, industry growth, and the association’s role in shaping the future of medical technology.
2025 Annual Report
2024 Annual Report
Our Quarterly Reports provide timely updates on advocacy efforts, regulatory developments, and organizational progress throughout the year.
Designed for quick insight, these reports offer snapshots of key activities and emerging issues impacting the medtech industry.
AdvaMed Advancements – Q2 2026 Report
AdvaMed Advancements – Q1 2026 Report
AdvaMed Advancements – Q4 2025 Report
AdvaMed Advancements – Q3 2025 Report
AdvaMed Advancements – Q2 2025 Report
AdvaMed Advancements – Q1 2025 Report
AdvaMed Advancements – Q4 2024 Report
AdvaMed Advancements – Q3 2024 Report
Become an AdvaMed® Member
Join over 500 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.